4. Materials and Methods
General information: All chemicals and reagents were purchased from Chemtronica (Uppsala, Sweden) and Sigma-Aldrich (St. Louis, MO, USA) and used as received unless otherwise stated. The amides and 1,3-diynes were prepared according to previously reported procedures and confirmed by NMR analysis [
6]. Silica gel (60 Å) was used for purification of crude mixtures. Gradient elution was performed using mixtures of petroleum ether and ethyl acetate or petroleum ether and acetone, with TLC analysis performed on silica gel sheets (aluminum foils with a 254 nm fluorescence indicator) purchased from Sigma-Aldrich (St. Louis, MO, USA). All NMR spectra were recorded on a Bruker Avance 400 Ascend spectrometer (Bruker BioSpin, Billerica, MA, USA). CDCl
3 was used as the NMR solvent. Chemical shifts (δ) are reported in ppm, with spectra referenced to residual non-deuterated solvent signals or TMS. HRMS data were obtained from Stockholm University and recorded on a Waters I-Class UPLC coupled with a XEVO G2-XS QToF instrument (Waters Corporation, Milford, MA, USA) using MSE acquisition mode, 50–1200 m/z, in positive or negative ESI mode. IR spectra were recorded using an Agilent Cary 630 FTIR spectrometer equipped with an ATR accessory (Agilent Technologies, Santa Clara, CA, USA). Melting points (uncorrected) were recorded using a Stuart Scientific SMP1 melting point apparatus (Stuart Equipment, Staffordshire, UK). Chemical structures were drawn using ChemDraw Professional 22.0 (ChemDraw 22.2.0.3348) (PerkinElmer Informatics, Waltham, MA, USA). NMR spectra were processed using MestReNova 14.2 (Mestrelab Research, Santiago de Compostela, Spain). Compounds
5,
7 and
9 are known [
17,
18], and their analytical data are consistent with those previously reported in the literature. The NMR and HRMS spectra of all synthesized compounds are provided in the
Supplementary Materials.
General procedure for the preparation of non-ionic deep eutectic liquids: Non-ionic deep eutectic solvents were prepared in a test tube following a previously reported procedure. The mixture was heated to 65–80 °C and stirred continuously for 30 min until a homogeneous liquid formed.
General procedure for the synthesis of benzosultams: In a thoroughly dried reaction tube equipped with a magnetic stir bar, sulfonamide 1 (0.285 mmol), Co(OAc)2·4H2O (30 mol %), 1,3-diyne 2 (0.19 mmol), Mn(OAc)3·2H2O (1.5 equiv.), and PhCOONa (2 equiv.) were combined. Following this, the deep eutectic liquid (2 mL) was introduced to the reaction mixture. The reaction mixture was stirred at 100 °C for 23 h. Upon completion of the reaction, 2 mL of deionized water and 5 mL of ethyl acetate were added to the reaction tube, and the mixture was subjected to sonication for approximately 15 min. The mixture was then transferred to a separation funnel, and an additional 5 mL of ethyl acetate was added. After thorough mixing, the organic phase, which contained the desired organic compounds, was extracted. The aqueous phase was subsequently washed twice with 10 mL of ethyl acetate. The combined organic extracts were collected and dried over magnesium sulfate. Following filtration and solvent evaporation, the product was purified using flash column chromatography on silica gel using petroleum ether/acetone (70:30) or petroleum ether/ethyl acetate (60:40) as the eluent, to obtain the desired product (3). The same general procedure was applied to the C—H activation of both phosphonamide and carboxamide substrates.
4-(phenoxymethyl)-3-(3-phenoxyprop-1-yn-1-yl)-2-(quinolin-8-yl)-2H-benzo[e][1,2]thiazine 1,1-dioxide (3a):
The crude reaction mixture was purified by flash column chromatography on silica gel using petroleum ether/acetone (70:30, v/v) to afford compound 3a in 11%. MP: 99–104 °C. 1H NMR (400 MHz, CDCl3) δ 8.76 (dd, J = 4.2, 1.8 Hz, 1H), 8.14 (dd, J = 8.4, 1.8 Hz, 1H), 7.94–7.82 (m, 4H), 7.78 (dd, J = 7.4, 1.5 Hz, 1H), 7.69 (td, J = 7.8, 1.4 Hz, 1H), 7.58 (dd, J = 7.8, 1.1 Hz, 2H), 7.50 (t, J = 7.8 Hz, 2H), 7.43–7.35 (m, 2H), 7.35–7.29 (m, 2H), 7.10 (dd, J = 8.7, 7.2 Hz, 3H), 7.06–6.98 (m, 3H), 6.92 (dddt, J = 9.1, 6.6, 3.5, 1.8 Hz, 2H), 6.58–6.50 (m, 2H), 5.41–5.24 (m, 3H), 4.45 (d, J = 8.6 Hz, 2H). 13C NMR (101 MHz, CDCl3) δ 158.5, 157.0, 151.1, 145.5, 135.8, 133.8, 133.6, 132.6, 132.0, 131.3, 129.7, 129.5, 129.3, 129.3, 129.2, 129.0, 128.6, 128.5, 126.7, 125.9, 125.8, 122.2, 121.9, 121.7, 121.4, 115.3, 114.4, 94.3, 80.1. HRMS m/z [M + H]+ Calcd for [C34H24N2O4S+] 545.6325, found = 545.6323.
6-methyl-4-(phenoxymethyl)-3-(3-phenoxyprop-1-yn-1-yl)-2-(quinolin-8-yl)-2H-benzo[e][1,2]thiazine 1,1-dioxide (3b)
The crude reaction mixture was purified by flash column chromatography on silica gel using petroleum ether/acetone (70:30, v/v) to afford compound 3b in 26%. MP = 113–116 °C; 1H NMR (400 MHz, CDCl3) δ 8.79 (dd, J = 4.2, 1.7 Hz, 1H), 8.14 (dd, J = 8.4, 1.7 Hz, 1H), 7.87–7.75 (m, 3H), 7.68–7.63 (m, 1H), 7.50 (dd, J = 8.2, 7.4 Hz, 1H), 7.42–7.27 (m, 5H), 7.14–7.07 (m, 2H), 7.07–6.99 (m, 3H), 6.95–6.87 (m, 1H), 6.57–6.49 (m, 2H), 5.29 (s, 2H), 4.42 (d, J = 8.2 Hz, 2H), 2.50 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 158.6, 157.0, 151.1, 145.5, 142.6, 135.8, 133.7, 132.6, 131.2, 131.1, 129.6, 129.6, 129.5, 129.5, 129.3, 129.0, 126.8, 126.0, 125.8, 121.9, 121.9, 121.7, 121.4, 115.4, 114.9, 114.4, 94.2, 80.2, 66.5, 55.5, 22.0. HRMS m/z [M + H]+ Calcd for [C34H26N2O4S+] 559.1613, found = 559.1685.
6-(tert-butyl)-4-(phenoxymethyl)-3-(3-phenoxyprop-1-yn-1-yl)-2-(quinolin-8-yl)-2H-benzo[e][1,2]thiazine 1,1-dioxide (3c)
The crude reaction mixture was purified by flash column chromatography on silica gel using petroleum ether/acetone (70:30, v/v) to afford compound 3c in 53%. MP = 139–141 °C. 1H NMR (400 MHz, CDCl3) δ 8.83 (dd, J = 4.2, 1.7 Hz, 1H), 8.15 (dd, J = 8.3, 1.7 Hz, 1H), 7.92–7.87 (m, 1H), 7.84 (d, J = 8.3 Hz, 2H), 7.76 (dd, J = 7.4, 1.4 Hz, 1H), 7.60 (dd, J = 8.3, 1.8 Hz, 1H), 7.49 (dd, J = 8.2, 7.4 Hz, 1H), 7.39 (dd, J = 8.3, 4.2 Hz, 1H), 7.37–7.27 (m, 3H), 7.15–7.08 (m, 2H), 7.06–7.00 (m, 3H), 6.92 (t, J = 7.3 Hz, 1H), 6.55 (d, J = 7.6 Hz, 2H), 5.34 (d, J = 3.3 Hz, 2H), 4.44 (d, J = 9.9 Hz, 2H), 1.36 (s, 9H). 13C NMR (101 MHz, CDCl3) δ 158.5, 157.1, 155.6, 151.1, 145.5, 135.8, 133.8, 132.2, 131.1, 131.0, 129.6, 129.6, 129.5, 129.3, 129.0, 126.5, 126.1, 125.8, 122.8, 122.3, 121.7, 121.7, 121.4, 121.4, 115.4, 114.5, 94.2, 80.2, 66.7, 55.5, 35.3, 31.1. HRMS m/z [M + H]+ Calcd for [C37H32N2O4S+] 601.2083, found = 601.2153.
6-methoxy-4-(phenoxymethyl)-3-(3-phenoxyprop-1-yn-1-yl)-2-(quinolin-8-yl)-2H-benzo[e][1,2]thiazine 1,1-dioxide (3d)
The crude reaction mixture was purified by flash column chromatography on silica gel using petroleum ether/ethyl acetate (60:40, v/v) to afford compound 3d in 18%. MP = 84–88 °C. 1H NMR (400 MHz, CDCl3) δ 8.80 (dd, J = 4.2, 1.7 Hz, 1H), 8.14 (dd, J = 8.3, 1.8 Hz, 1H), 7.88–7.74 (m, 3H), 7.50 (dd, J = 8.2, 7.4 Hz, 1H), 7.41–7.36 (m, 1H), 7.35–7.30 (m, 3H), 7.14–6.99 (m, 6H), 6.95–6.89 (m, 1H), 6.56–6.51 (m, 2H), 5.28 (s, 2H), 4.42 (d, J = 8.1 Hz, 2H), 3.86 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 162.3, 158.5, 157.0, 151.1, 145.5, 135.8, 134.6, 133.7, 131.2, 129.6, 129.5, 129.3, 129.0, 127.3, 126.4, 125.8, 123.9, 121.7, 121.4, 121.4, 121.4, 115.4, 114.8, 114.4, 110.2, 94.4, 80.2, 66.7, 55.6, 55.5. HRMS m/z [M + H]+ Calcd for [C34H26N2O5S+] 575.1636, found = 575.1635
6-iodo-4-(phenoxymethyl)-3-(3-phenoxyprop-1-yn-1-yl)-2-(quinolin-8-yl)-2H-benzo[e][1,2]thiazine 1,1-dioxide (3e)
The crude reaction mixture was purified by flash column chromatography on silica gel using petroleum ether/acetone (70:30, v/v) to afford compound 3e in 9%. MP = 71–74 °C. 1H NMR (400 MHz, CDCl3) δ 8.73 (dd, J = 4.2, 1.7 Hz, 1H), 8.25 (d, J = 1.5 Hz, 1H), 8.14 (dd, J = 8.3, 1.7 Hz, 1H), 7.88 (ddd, J = 18.1, 8.3, 1.5 Hz, 2H), 7.79 (td, J = 6.9, 6.4, 1.5 Hz, 2H), 7.60 (d, J = 8.2 Hz, 1H), 7.54–7.46 (m, 2H), 7.39 (dd, J = 8.3, 4.2 Hz, 1H), 7.35–7.29 (m, 2H), 7.15–7.07 (m, 2H), 7.07–6.99 (m, 3H), 6.96–6.90 (m, 1H), 6.57–6.52 (m, 2H), 5.26 (s, 2H), 4.45 (d, J = 6.5 Hz, 2H).13C NMR (101 MHz, CDCl3) δ 158.4, 157.0, 151.1, 145.3, 137.3, 135.8, 134.7, 134.2, 133.5, 132.8, 131.4, 129.8, 129.5, 129.3, 129.0, 128.5, 127.6, 125.8, 123.2, 121.8, 121.6, 121.5, 121.0, 115.5, 114.7, 99.0, 95.1, 79.9, 66.3, 55.5. HRMS m/z [M + H]+ Calcd for [C33H23IN2O4S+] 671.0496, found = 671.0515
6-fluoro-4-(phenoxymethyl)-3-(3-phenoxyprop-1-yn-1-yl)-2-(quinolin-8-yl)-2H-benzo[e][1,2]thiazine 1,1-dioxide (3f)
The crude reaction mixture was purified by flash column chromatography on silica gel using petroleum ether/acetone (70:30, v/v) to afford compound 3f in 7%. MP = 167–169 °C. 1H NMR (400 MHz, CDCl3) δ 8.74 (dd, J = 4.2, 1.7 Hz, 1H), 8.15 (dd, J = 8.4, 1.7 Hz, 1H), 7.94–7.78 (m, 3H), 7.58 (dd, J = 10.3, 2.4 Hz, 1H), 7.51 (dd, J = 8.2, 7.4 Hz, 1H), 7.39 (dd, J = 8.3, 4.2 Hz, 1H), 7.36–7.28 (m, 2H), 7.26 (td, J = 8.3, 2.4 Hz, 1H), 7.11 (dd, J = 8.7, 7.3 Hz, 2H), 7.07–6.99 (m, 2H), 7.03–6.97 (m, 1H), 6.97–6.89 (m, 1H), 6.58–6.51 (m, 1H), 5.26 (s, 2H), 4.45 (d, J = 6.6 Hz, 2H). 19F NMR (376 MHz, CDCl3) δ −105.34, −105.36, −105.36, −105.37, −105.38, −105.38, −105.39, −105.41. 13C NMR (101 MHz, CDCl3) δ 164.7 (d, J = 251.6 Hz), 158.5, 157.2, 151.3, 145.5, 136.0, 135.7 (d, J = 9.4 Hz), 133.6, 131.6, 130.0, 129.9 (d, J = 2.9 Hz), 129.7, 129.5, 129.2, 128.7, 128.0, 127.0, 125.9, 124.8 (d, J = 10.0 Hz), 122.0, 121.7, 121.6, 121.4 (d, J = 2.7 Hz), 116.2 (d, J = 23.4 Hz), 115.5, 114.6, 112.8 (d, J = 24.7 Hz), 95.3, 80.1, 66.6, 55.6. HRMS m/z [M + H]+ Calcd for [C33H23N2O4S+] 563.1436, found = 563.1435.
6-(tert-butyl)-4-butyl-3-(hex-1-yn-1-yl)-2-(quinolin-8-yl)-2H-benzo[e][1,2]thiazine 1,1-dioxide (3g):
The crude reaction mixture was purified by flash column chromatography on silica gel using petroleum ether/acetone (70:30, v/v) to afford compound 3g in 18%. MP = 117–120 °C; 1H NMR (400 MHz, CDCl3) δ 8.77 (dd, J = 4.2, 1.7 Hz, 1H), 8.06 (dd, J = 8.3, 1.7 Hz, 1H), 7.75 (dd, J = 8.2, 1.4 Hz, 1H), 7.71 (d, J = 8.2 Hz, 1H), 7.64–7.58 (m, 2H), 7.48–7.41 (m, 2H), 7.30 (dd, J = 8.3, 4.2 Hz, 1H), 2.95–2.88 (m, 2H), 1.92 (t, J = 6.8 Hz, 2H), 1.64–1.55 (m, 2H), 1.40 (q, J = 7.4 Hz, 2H), 1.33 (s, 10H), 0.89 (t, J = 7.3 Hz, 5H), 0.76–0.68 (m, 2H), 0.51 (t, J = 7.2 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 154.9, 150.9, 145.8, 135.6, 134.9, 132.9, 131.6, 130.6, 129.0, 128.8, 126.9, 125.7, 125.1, 124.0, 121.9, 121.8, 121.8, 121.5, 99.3, 75.5, 35.3, 31.3, 31.2, 29.8, 29.8, 22.5, 21.2, 18.9, 14.0, 13.3. HRMS m/z [M + H]+ Calcd for [C31H36N2O2S+] 501.2571, found = 501.2570.
6-(tert-butyl)-4-phenethyl-3-(4-phenylbut-1-yn-1-yl)-2-(quinolin-8-yl)-2H-benzo[e][1,2]thiazine 1,1-dioxide (3h)
The crude reaction mixture was purified by flash column chromatography on silica gel using petroleum ether/acetone (70:30, v/v) to afford compound 3h in 34%. MP = 97–99 °C. 1H NMR (400 MHz, CDCl3) δ 8.87 (dd, J = 4.2, 1.7 Hz, 1H), 8.19 (ddd, J = 8.3, 3.7, 1.7 Hz, 1H), 7.92–7.81 (m, 2H), 7.79–7.74 (m, 1H), 7.69 (d, J = 1.8 Hz, 1H), 7.61–7.52 (m, 2H), 7.42 (dd, J = 8.3, 4.1 Hz, 1H), 7.36–7.27 (m, 3H), 7.27–7.21 (m, 3H), 7.20–7.13 (m, 3H), 6.93–6.86 (m, 2H), 3.23 (ddd, J = 8.9, 6.5, 4.1 Hz, 2H), 2.98 (ddt, J = 15.7, 10.0, 7.3 Hz, 2H), 2.33 (t, J = 2.5 Hz, 3H), 1.42 (s, 9H). 13C NMR (101 MHz, CDCl3) δ 155.1, 151.0, 145.8, 141.7, 140.0, 135.8, 134.7, 132.8, 131.5, 130.9, 129.0, 128.5, 128.3, 128.3, 128.0, 126.3, 126.2, 126.1, 125.8, 125.4, 124.4, 121.9, 121.6, 121.6, 99.1, 75.9, 35.8, 35.3, 34.2, 32.6, 31.2, 31.2, 21.3. HRMS m/z [M + H]+ Calcd for [C39H36N2O2S+] 597.2571, found = 597.2570.
6-(tert-butyl)-4-phenyl-3-(phenylethynyl)-2-(quinolin-8-yl)-2H-benzo[e][1,2]thiazine 1,1-dioxide + 6-(tert-butyl)-3-phenyl-4-(phenylethynyl)-2-(quinolin-8-yl)-2H-benzo[e][1,2]thiazine 1,1-dioxide (3i & 3i′)
The crude reaction mixture was purified by flash column chromatography on silica gel using petroleum ether/acetone (70:30, v/v) to afford compound 3i & 3i′ in 34%. MP: 120–132 °C. 1H NMR (400 MHz, CDCl3) δ 8.94 (ddd, J = 19.3, 4.2, 1.7 Hz, 2H), 8.35 (d, J = 1.8 Hz, 1H), 8.22 (dd, J = 8.3, 1.7 Hz, 1H), 8.08–7.89 (m, 9H), 7.81 (d, J = 8.3 Hz, 1H), 7.70–7.55 (m, 5H), 7.55–7.46 (m, 4H), 7.46–7.40 (m, 3H), 7.40–7.31 (m, 6H), 7.30–7.22 (m, 5H), 7.18–7.10 (m, 3H), 7.08–7.01 (m, 2H), 6.55–6.50 (m, 2H), 1.51 (s, 6H), 1.26 (s, 9H). 13C NMR (101 MHz, CDCl3) δ 155.7, 155.2, 151.1, 150.8, 147.3, 145.7, 145.3, 136.5, 136.0, 135.6, 135.0, 134.7, 134.3, 134.0, 133.1, 131.5, 131.2, 131.1, 131.0, 130.9, 130.6, 130.0, 129.4, 129.4, 129.3, 129.1, 128.8, 128.8, 128.5, 128.4, 128.1, 128.1, 128.1, 128.0, 127.9, 127.2, 125.9, 125.8, 125.7, 125.5, 124.7, 124.5, 124.3, 123.4, 121.8, 121.7, 121.6, 106.7, 97.8, 94.7, 86.1, 85.0, 35.5, 35.2, 31.2, 31.0. HRMS m/z [M + H]+ Calcd for [C35H28N2O2S+] 541.1945, found = 541.1943.
6-(tert-butyl)-3-phenethyl-2-(quinolin-8-yl)-2H-benzo[e][1,2]thiazine 1,1-dioxide (9)
The crude reaction mixture was purified by flash column chromatography on silica gel using petroleum ether/acetone (70:30, v/v) to afford compound 9 in 26%. 1H NMR (400 MHz, CDCl3) δ 8.79 (dd, J = 4.2, 1.7 Hz, 1H), 8.09 (dd, J = 8.3, 1.7 Hz, 1H), 7.80 (dd, J = 8.3, 1.5 Hz, 1H), 7.67–7.60 (m, 2H), 7.47 (dd, J = 8.2, 7.3 Hz, 1H), 7.39 (dd, J = 8.3, 1.8 Hz, 1H), 7.37–7.29 (m, 2H), 7.12–7.00 (m, 3H), 6.90–6.85 (m, 2H), 6.34 (s, 1H), 2.90 (s, 1H), 2.83 (t, J = 8.0 Hz, 2H), 2.32 (qt, J = 15.4, 7.9 Hz, 2H), 1.30 (s, 9H). 13C NMR (101 MHz, CDCl3) δ 155.4, 151.4, 145.9, 143.7, 140.8, 135.9, 133.5, 132.9, 130.8, 129.5, 128.5, 128.4, 128.3, 126.0, 125.9, 124.7, 123.6, 121.9, 121.7, 109.5, 36.5, 35.1, 34.1, 31.2, 31.2. HRMS m/z [M + H]+ Calcd for [C29H28N2O2S+] 469.1944, found = 469.1941.